Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
1.080
-0.020 (-1.82%)
Nov 3, 2025, 2:03 PM EST - Market open
Biofrontera Market Cap
Biofrontera has a market cap or net worth of $11.52 million as of November 3, 2025. Its market cap has increased by 173.52% in one year.
Market Cap
11.52M
Enterprise Value
9.49M
1-Year Change
173.52%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since the IPO on October 29, 2021, Biofrontera's market cap has decreased from $35.28M to $11.52M, a decrease of -67.34%. That is a compound annual growth rate of -24.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 11.74M | 38.93% |
| Dec 31, 2024 | 8.45M | 100.93% |
| Dec 29, 2023 | 4.20M | -82.82% |
| Dec 30, 2022 | 24.47M | -80.97% |
| Dec 31, 2021 | 128.63M | 264.59% |
| Oct 29, 2021 | 35.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |